Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs

17 Jan 2009

Abstract excerpt

BACKGROUND: Affecting both livestock and humans, Rift Valley Fever is considered as one of the most important viral zoonoses in Africa. However, no licensed vaccines or effective treatments are yet available for human use. Naked DNA vaccines are an interesting approach since the virus is highly infectious and existing attenuated Rift Valley Fever virus vaccine strains display adverse effects in animal trials. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Vector-Borne Animal Diseases
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19149901
DOI: 10.1186/1743-422x-6-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructsPMID 19149901Read ↗

Virus-Like Particles Expressing the Nucleocapsid Gene as an Efficient Vaccine Against Rift Valley Fever VirusSemantic proximity Read ↗

The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculationSemantic proximity Read ↗

Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in miceSemantic proximity Read ↗

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in miceSemantic proximity Read ↗

Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent modelsSemantic proximity Read ↗

Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR−/− mice induced by different DNA vaccination regimensSemantic proximity Read ↗

Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged MiceSemantic proximity Read ↗

Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunizationSemantic proximity Read ↗

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challengeSemantic proximity Read ↗

Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever VirusSemantic proximity Read ↗

Perspectives of Next-Generation Live-Attenuated Rift Valley Fever Vaccines for Animal and Human UseSemantic proximity Read ↗

Single-Dose Immunization with Virus Replicon Particles Confers Rapid Robust Protection against Rift Valley Fever Virus ChallengeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.